| | UAE's Abu Dhabi received its first shipment of the coronavirus Sotrovimab medication, becoming the first city globally to receive it, the media office said on a tweet on Wednesday. | | | The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. | | | Mexico reported 3,789 coronavirus cases and an additional 196 fatalities on Wednesday, according to health ministry data, bringing the total number of cases to 2,463,390 and the overall death toll to 230,624. | | | At least 200,000 refugees are among the worst affected by India's COVID-19 outbreak as they have no access to welfare schemes or free healthcare, a report by an international consortium of rights groups said on Wednesday. | | | The United States has administered 312,915,170 doses of COVID-19 vaccines and distributed 375,186,675 doses in the country as of Wednesday morning, the U.S. Centers for Disease Control and Prevention said. | | | It will be mandatory for care home workers in England to have coronavirus vaccinations, British health minister Matt Hancock said on Wednesday, adding the government was considering whether the policy should be extended to healthcare workers too. | | | The primary issue with lagging COVID-19 vaccinations in the Americas is access to doses, not acceptance of vaccine safety or efficacy, the Pan American Health Organization (PAHO) said on Wednesday, urging donor countries to send shots as soon as possible. | | | Johnson & Johnson (JNJ.N) is expected to miss its COVID-19 vaccine supply target to the European Union for the second quarter after millions of doses were banned for use in Europe over safety concerns, an EU Commission spokesman said. | | | Boris Johnson's former chief adviser reignited a campaign of criticism of the government on Wednesday, publishing a text message exchange in which the British leader branded his health minister's coronavirus testing drive "hopeless". | | | Swiss drugmaker Novartis AG (NOVN.S) has received breakthrough therapy designation from the U.S. Food and Drug Administration for an experimental treatment for advanced castration-resistant prostate cancer, the company said on Wednesday. | | | | |